Kirk Campbell, MD

Dr. Kirk Campbell is the Irene and Dr. Arthur M. Fishberg Professor of Medicine in the Division of Nephrology, and Professor of Pharmacological Sciences at the Icahn School of Medicine at Mount Sinai. Dr. Campbell is the inaugural Director of the Mount Sinai Center for Kidney Disease Innovation. In addition to caring for patients with kidney disease, he leads a multidisciplinary research program focused on understanding mechanisms of kidney disease progression and clinical trials in the rare kidney disease space. The work centers on advancing the understanding of underlying mechanisms involved in kidney progression while identifying targets for therapeutic intervention.

He has been a principal investigator and steering committee member for multiple clinical trials testing novel agents for focal segmental glomerulosclerosis (FSGS), IgA nephropathy, lupus nephritis and membranous nephropathy. Dr. Campbell is the principal investigator for Mount Sinai’s Kidney Precision Medicine Recruitment Site. He is an elected member of the American Society for Clinical Investigation and a member of the Editorial Boards of American Journal of Kidney Disease, Kidney360, Kidney International, Frontiers in Medicine and the American Journal of Physiology – Renal Physiology.

New York, NY